StockData
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

TREACE MEDICAL CONCEPTS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.88+0.01 (+0.26%)

Close on Oct 19, 2026

Market cap
$252.39M
P/E (TTM)
–
Dividend yield
–

TREACE MEDICAL CONCEPTS, INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Treace Medical Concepts does not break out revenue by segment, region or product in the tagged data of its filings for this period type.